iproniazid has been researched along with ascorbic acid in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (53.33) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Goromaru, T; Hongu, Y; Kiwada, H; Matsuki, Y; Noda, Y; Sakurai, H | 1 |
| Glazigna, L; Maina, G; Rumney, G | 1 |
| Baru, AM; Rasin, MS | 1 |
| Aunis, D; Mandel, P; Miras-Portugal, MT | 1 |
| Adams, C; Hulsey, BS; Lindsay, RH | 1 |
| Takahashi, H | 1 |
| Bandou, R; Goromaru, T; Kiwada, H; Maeda, H; Matsuki, Y | 1 |
| DE SCHAEPDRYVER, A; PREZIOSI, P | 1 |
| MANCA, P; MIELE, E; PASSARELLI, E; PREZIOSI, P | 1 |
| SAPEIKA, N | 1 |
1 review(s) available for iproniazid and ascorbic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
14 other study(ies) available for iproniazid and ascorbic acid
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
[Effects of ascorbic acid on the metabolic fate and the free radical formation of iproniazid].
Topics: Animals; Ascorbic Acid; Free Radical Scavengers; Free Radicals; Iproniazid; Male; Rats; Rats, Wistar | 1992 |
Role of L-ascorbic acid in the reversal of the monoamine oxidase inhibition by caffeine.
Topics: Animals; Ascorbic Acid; Caffeine; Ephedrine; Haplorhini; In Vitro Techniques; Iproniazid; Mitochondria, Liver; Monoamine Oxidase Inhibitors; Oxidation-Reduction; Rats; Serotonin; Tyramine; Uric Acid | 1971 |
[Activation of the pituitary-adrenocortical system, caused by the blockade of noradrenaline biosynthesis].
Topics: 11-Hydroxycorticosteroids; Adrenal Glands; Animals; Ascorbic Acid; Epinephrine; Hypothalamus; Imipramine; Iproniazid; Male; Norepinephrine; Pituitary-Adrenal System; Rats; Reserpine; Thiocarbamates | 1974 |
Inhibition of adrenal dopamine-beta-hydroxylase by 6-hydroxy dopamine.
Topics: Adrenal Medulla; Animals; Ascorbic Acid; Catalase; Cattle; Chromaffin System; Depression, Chemical; Dopamine beta-Hydroxylase; Drug Interactions; Hydrogen Peroxide; Hydroxydopamines; In Vitro Techniques; Iproniazid; Kinetics; Liver; Molecular Weight; Oxidation-Reduction; Pargyline; Proteins; Serum Albumin, Bovine; Time Factors; Tyramine | 1973 |
The relationship of epinephrine oxidation to rat parotid metabolism and secretion in vitro.
Topics: Adrenochrome; Amylases; Animals; Ascorbic Acid; Carbon Isotopes; Epinephrine; Glucose; Iproniazid; Leucine; Male; Parotid Gland; Protein Biosynthesis; Rats; Sulfites | 1971 |
[Mode of anti-inflammatory action of sodium salicylate and its relationship to the pituitary-adrenal axis].
Topics: Adrenalectomy; Animals; Anti-Inflammatory Agents; Ascorbic Acid; Ascorbic Acid Deficiency; Axis, Cervical Vertebra; Dibenzylchlorethamine; Edema; Epinephrine; Hexamethonium Compounds; Iproniazid; Male; Metyrapone; Pituitary-Adrenal System; Rats; Sodium Salicylate; Time Factors | 1968 |
Effects of ascorbic acid on iproniazid-induced hepatitis in phenobarbital-treated rats.
Topics: Alanine Transaminase; Aminopyrine; Animals; Ascorbic Acid; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Chromatography, Gas; Hydrazines; Iproniazid; Kinetics; Liver; Liver Function Tests; Male; Phenobarbital; Rats; Rats, Wistar | 1994 |
[Insulin- and reserpine-induced changes of the content of catecholamine, ascorbic acid and cholesterol of the adrenal with or without iproniazid pretreatment].
Topics: Adrenal Glands; Ascorbic Acid; Catecholamines; Cholesterol; Insulin; Iproniazid; Isomerism; Lipid Metabolism; Niacin; Nicotinic Acids; Reserpine | 1959 |
[ADRENAL CORTEX CHANGES DUE TO RESERPINE, FORMALIN AND PIROMEN IN ANIMALS PRETREATED OR NOT WITH IPRONIAZID].
Topics: Adrenal Cortex; Adrenal Glands; Ascorbic Acid; Cholesterol; Formaldehyde; Iproniazid; Pharmacology; Polysaccharides; Polysaccharides, Bacterial; Rats; Research; Reserpine | 1963 |
The effect of chlorpromazine, iproniazid, and chloroquine on adrenal ascorbic acid in the rat.
Topics: Adrenal Cortex; Animals; Ascorbic Acid; Carbohydrate Metabolism; Chloroquine; Chlorpromazine; Iproniazid; Rats | 1959 |